Table 1.
Freyer et al | Wang et al | Index patient | |
---|---|---|---|
Ancestry | Syrian | – | Chinese |
Parents | Consanguineous | Consanguineous | Nonconsanguineous |
Antenatal | Oligohydramnios, fetal lung hypoplasia, growth retardation | Gestational diabetes | Oligohydramnios, growth retardation, fetal cardiomegaly |
Gestational age | Full term | 37 wk | 33 wk |
Respiratory | Lung hypoplasia with persistent pulmonary hypertension of newborn | – | Central hypoventilation |
Renal | Renal dysfunction with small dysplastic kidneys with impaired cortical differentiation (resolved upon follow‐up) | – | Multiple renal cysts and diffuse increase in renal parenchymal echogenicity with accentuation of cortico‐medullary differentiation |
Cardiovascular | Left ventricular cardiac hypertrophy (with subsequent regression), systemic hypertension | – | Severe hypertrophic cardiomyopathy with pericardial effusion, moderate tricuspid regurgitation |
Growth and feeding | Postnatal growth retardation with oromotor dysfunction requiring gastrostomy | Normal | Postnatal growth retardation with oromotor dysfunction requiring tube feeding |
Neurology and developmental outcome | Normal MRI brain | Normal MRI brain | MRI brain showed subdural hematoma, basal ganglial and thalami hypodensities with abnormal lactate peak |
Distal contractures since birth with progressive peripheral sensorimotor polyneuropathy, axonal, and demyelinating type | Generalized muscle wasting, more prominent in the legs, also affecting temporalis muscle | Generalized hypotonia with progressive myopathy clinically | |
Mild learning difficulties at 9 y old, never learned to stand or walk independently | Normal early developmental milestones, followed by language delay since 14 mo, progressive motor regression since second year and became wheelchair bound at 3 | Global developmental delay with developmental age below 3 mo across all domains at 1 y | |
Hearing | Combined sensorineural and conduction hearing impairment | Bilateral low frequency sensorineural hearing loss | Bilateral profound hearing impairment in range of 2‐4 Hz |
Vision | Visual dysfunction | – | Lack of visual following |
Respiratory chain enzyme activities | Complex I + III and IV deficiency | – | Complex II + III deficiency with normal isolated activity of complex II and complex III |
COQ7 variants identified | p.(Val141Glu) | p.(Leu111Pro) | p.(Lys200Ilefs*56), p.(Arg107Trp) |
Response to treatment | Dosage of CoQ10 not available | CoQ10 11.4 mg/kg twice daily | CoQ10 4 mg/kg/day since 2 mo |
Regression stalled | No obvious improvement | Stepped up to 20 mg/kg/day at 1 y | |
Significant reduction in neuromuscular pain | No deterioration or worsening spasticity | No obvious response to treatment |
Abbreviation: MRI, magnetic resonance imaging; y, years; mo, months.